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ABSTRACT 
 
 Mulan is an E3 ubiquitin ligase embedded in the outer mitochondria membrane. Mulan’s 
participation in the ubiquitination process is conducted through its cytosol-exposed RING finger 
domain, and its ability to modulate protein ubiquitination makes it a key player in mitochondrial 
and cellular homeostasis. Mulan is known to be involved in mitochondrial fission, fusion, 
mitochondrial stress, apoptosis, and Parkin-independent mitophagy. Dysregulation of Mulan in 
mice has been shown to correlate with human neurodegenerative disorders and heart disease. 
Accumulation of Mulan is predicted to be responsible for the motor neuron degeneration 2 
(mnd2) phenotype in mutant mice through the deregulation of the Mulan-dependent pathway of 
mitophagy. The purpose of this study was to utilize both a yeast two-hybrid screen as well as an 
in vitro profiling assay to characterize interactions between Mulan and potential E2 conjugating 
enzymes. Through these studies, Ube2D1, Ube2D2, and Ube2D3 were identified as strong 
interactors with the Mulan-RING domain. The tissue specific expression and protein levels of 
these E2 conjugating enzymes was further investigated in mouse tissues by SDS-PAGE and 
Western blot analysis. They all had similar patterns of expression and were present in brain, 
heart, kidney, and liver tissues, with the highest level seen in the brain. This data demonstrates 
that Mulan has a primary function in the brain and it suggests that Mulan’s deregulation might be 
involved in the development and progression of neurodegeneration. 
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CHAPTER 1: INTRODUCTION AND REVIEW OF LITERATURE 
 
 Mitochondria ubiquitin ligase activator of NF-κB (Mulan), also coined Mitochondria-
anchored protein ligase (MAPL), growth inhibition death E3 ligase (GIDE), Hades, 
Mitochondrial ubiquitin protein ligase 1 (Mul1), C1orf166, and RNF218, is one of three E3 
ubiquitin ligases located within the outer mitochondrial membrane (OMM) [1-5]. Mulan is a 
352-amino acid protein with a molecular weight of 39.8 kDa. The protein includes two 
transmembrane domains (TMDs) and it is orientated in the OMM such that both the N- and C- 
termini face the cytosol, leaving a large BAM (beside a membrane) / GIDE domain within the 
intermembrane space (IMS) (Figure 1) [6]. The C-terminus includes a RING finger domain, the 
key component for Mulan’s E3 ligase activity and a major regulator of cellular and 
mitochondrial dynamics. An intact RING finger (amino acids 259-352) and proper localization 
to the mitochondria is required for Mulan’s participation in cell growth, mitophagy, 
mitochondrial fission/fusion, apoptosis and vesicle transport [1]. The BAM-RING regions are 
highly conserved, supported through phylogenetic analysis that determined Mulan to be present 
with the origin of holozoan and viridiplantae lineages [6]. Mulan is expressed ubiquitously with 
the highest expression in the heart, placenta, liver, kidney, and brain [1]. 
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A. Schematic diagram indicating the three mitochondrial E3 ubiquitin ligases and their 
topology on the OMM. 
B. Mulan is a 352-residue protein, and includes two TMDs, a BAM/GIDE domain within 
the IMS, and the RING finger domain facing the cytosol. The RING finger domain is 
responsible for the ligase activity of the protein. 
  
A. 
B. 
Figure 1: Mulan E3 ubiquitin ligase location and domains 
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1.1 The Ubiquitin-Proteasome System 
 
Mulan’s main molecular function is as an E3 ubiquitin ligase in the ubiquitination 
process. Ubiquitination is a cytosolic system of targeted protein degradation that uses ubiquitin 
(Ub) and a three-enzyme cascade. Ub is a small molecule (76 amino acids) that is covalently 
attached as a post-translational modification to a substrate [7]. Attachment occurs at the amino 
terminus or at internal lysine residues of the substrate by Ub’s C-terminal Gly76. Multiple 
rounds of ubiquitination result in a polyubiquitin (polyUb) tag, Ub molecules attaching to each 
other at one of seven internal lysine residues, with the Lys48 and Lys63 sites being the most 
frequently polyubiquitinated. Lys48 polyUb has been associated with degradation by the 26S 
proteasome [8]. PolyUb shuttles include a Ub-associating domain to bind to the Ub, a Ub-like 
domain to target the complex to the proteasome, and innate abilities to protect the polyUb tag 
from deubiquitinating enzymes (DUBs), the modulators for the reverse process [7].  
Ubiquitination occurs in a series of three steps with enzymes E1, E2, and E3: (1) E1 
activates ubiquitin, (2) E2 conjugates ubiquitin to a carrier, and (3) E3 ligates Ub to the substrate 
target (Figure 2). The human genome encodes 2 E1s, about 50 E2s, and approximately 700 E3s 
[9]. The two most common classes of E3 ubiquitin ligases include: RING finger proteins and 
HECT domain enzymes. For the RING finger E3 proteins, there is a complex formed between 
the E2, E3, and substrate for the Ub transfer, whereas HECT domains include a Ub-thiolester-
intermediate before transfer [7]. Mulan, as an E3 ubiquitin ligase of the RING finger protein 
class, participates in the direct translocation of the activated Ub from an E2 conjugating enzyme 
to the substrate, which often targets the substrate for degradation by the 26S proteasome. 
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SUMOylation is a similar process to ubiquitination that adds SUMO molecules onto 
targets as a post-translation modification. SUMO is a ubiquitin-like modifier that, when added, 
aids in a variety of cellular processes including localization, signaling, and maintenance of other 
post-translational modifications. SUMOylation also involves a three-enzyme cascade: (1) E1 
heterodimer, (2) E2 ligase Ubc9, and (3) and E3 ligase. Mulan has been reported to also function 
as an E3 SUMOylation ligase [10].     
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Ubiquitination is a process that involves three different steps with three different enzymes: an E1 
ubiquitin activator, an E2 conjugating enzyme, and an E3 ligating enzyme. Mulan is an E3 
ligating enzyme, responsible for tagging Ub molecules to substrates transferred from an E2. This 
transfer requires formation of a complex between E2, E3, and the substrate.  
Figure 2: The Ubiquitination process and Mulan E3 ubiquitin ligase 
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1.2 Mitochondrial Dynamics 
 
Mulan’s function has also been implicated in mitochondrial fusion, fission, apoptosis, and 
mitochondrial vesicle transport [1-3,10].  
Mitochondria are constantly adjusting their size, shape, and location, and together they 
exist in a coordinated network. These changes result from mitochondrial fusion (the combining 
of two mitochondria into one) and fission (the splitting of one mitochondrion into two) (Figure 
3). Fusion is controlled by mitofusin 1 and 2 (Mfn1 and Mfn2): the proteins are tethered to the 
OMM and their cytosolic component contains a GTPase responsible for binding an adjacent 
mitochondrion; OPA1, a dynamin-like GTPase located within the IMS or IMM, is responsible 
for IMM fusion and the regulation of cristae morphology [11]. Mulan ubiquitinates Mfn2 and 
targets it for degradation [5]. 
Mitochondrial fission is controlled by the GTPase Dynamin-related protein 1 (Drp1). An 
increase in Drp1 leads to an increase in fission. This protein is a substrate for Mulan’s E3 
SUMOylation activity. During induction of apoptosis, Mulan SUMOylates Drp1, which results 
in stabilization of a mitochondria-endoplasmic reticulum complex that permits calcium flux. In 
turn, this leads to cristae remodeling, and cytochrome c release, which activates the caspase 
dependent pathway of apoptosis [12].  
Overall, Mulan stabilization of Drp1 by SUMOylation and breakdown of Mfn2 by 
ubiquitination enhances fission and impedes fusion [13]. Mulan knockdown with siRNA has also 
been shown to result in mitochondrial perinuclear clustering, whereas Mulan accumulation has 
been shown to result in mitochondrial fragmentation [1,7]. 
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Apoptosis is a process of cell death and it can occur due to many forms of cellular stress, 
including OMM depolarization. Mulan is involved in apoptosis by ubiquitinating the tumor 
suppressor p53 and p73 proteins [4,14], as well as Akt, an antiapoptotic protein [15,16]. In 
addition, Mulan activates the protein kinase JNK just before the apoptosis associated caspase 
cascade is initiated [3]. In contrast, activation of the NF-κB transcription factor by Mulan during 
conditions of ER stress leads to the production of several antiapoptotic factors [17]. Therefore, 
Mulan’s placement in apoptosis often appears contradictory and the dynamics are still not highly 
understood.   
Lastly, one of Mulan’s initial functions was defined by its presence in mitochondrial-
derived vesicles (MDV) that fuse with peroxisomes. However, most peroxisomes do not contain 
Mulan, and only about 5-15 MDVs contain Mulan per cell. Vesicles that possess Drp1 were also 
found to block Mulan’s ability to cause mitochondria fragmentation and resulted in increased 
interconnectedness of the endoplasmic reticulum [2]. An interactor of Mulan, Vps35, is involved 
in Mulan-MDV formation and transport of Mulan to the peroxisome [18]. Vps35 deficiency 
leads to an increase in Mulan expression and mitochondrial fragmentation. Vps35 mutation is 
linked to familial PD [19].   
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Mitochondria alternate their shape and size through the processes of fission and fusion in order 
to maintain health and manage damage. Fission is the splitting of one mitochondrion into two 
and involves the Drp1protein. Fusion is the combining of two mitochondria to form one and 
involves the Mfn1, Mfn2, and OPA1 proteins. Damaged mitochondria exit the cycle through 
mitophagy.  
  
Figure 3: Mitochondrial fission and fusion 
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1.3 Mitophagy 
 
Autophagy is the process of cytoplasmic sequestering within an autophagosome and the 
subsequent degradation by the merging with a lysosome. Nutrient deprivation, starvation, or 
hormone release can result in autophagy for the salvaging of precursor metabolites, however, 
autophagy is a continuous process that requires no stress for baseline functioning [20]. 
Autophagosomes are double-membraned vesicles that work to isolate damaged or excess cellular 
material. The overall process of autophagy includes induction, formation of the autophagosome, 
fusion of the autophagosome with a lysosome, breakdown of the cellular components with the 
lysosome’s hydrolytic enzymes and release of the products into the cytosol [21].  
Mitophagy is a form of autophagy that specifically targets mitochondria for degradation 
and is responsible for maintaining a healthy mitochondrial population. The term “mitophagy” 
was coined to emphasize the selective and non-random nature of mitochondrial destruction [20]. 
Mitochondria may become damaged or dysfunctional, for example, through dysregulation of 
fission/fusion, through age, through mitochondrial permeability transition (MPT), or through an 
accumulation of reactive oxygen species (ROS) such as hydrogen peroxide, superoxide, and 
hydroxyl radical, the byproducts of oxidative phosphorylation in aerobic metabolism that cause 
mutation [7,20,21]. The ROS result in a depolarization of the mitochondrial membrane potential, 
an event that forces the signaling for autophagosome engulfment and mitophagy. Even in non-
proliferating tissues, mitochondria are still replaced every 10-25 days through the binary fission 
of pre-existing mitochondria to generate the new and mitophagy to destroy the old [20].  
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Mitophagy was first associated with PINK1 and Parkin, proteins whose gene mutations 
are linked to Parkinson’s Disease (PD). PINK1 is a mitochondrial targeted serine-threonine 
kinase and Parkin is an E3 ubiquitin ligase in the cytosol [5, 22, 23]. In healthy mitochondria 
with high membrane potential, PINK1 is imported into the mitochondria and degraded. When a 
mitochondrion is damaged, and the membrane potential is lowered, the import of PINK1 is 
inhibited and it accumulates on the OMM. PINK1 phosphorylates Ub and Mfn2, which then 
recruits Parkin. Binding of Parkin to the phospho-ubiquitin chain and further phosphorylation of 
Parkin by PINK1 directly leads to activation of Parkin’s ubiquitin ligase activity for OMM 
substrates. Extensive ubiquitination of OMM proteins leads to mitophagy. Parkin ubiquitinates 
p62, which binds LC3 and leads to autophagosome formation [24] (Figure 4).  
Studies on Drosophila indicate that downregulation of Mfn2, mitochondrial fusion 
promoting, and upregulation of Drp1, mitochondrial fission promoting, results in the suppression 
of PD phenotype when PINK1 or Parkin are absent [22]. Mitophagy can be induced in vitro with 
the mitochondrial uncoupler carbonyl cyanide m-chlorophenyl hydrazine (CCCP) for study 
purposes [23].  
The role of Parkin as a universal inducer of mitophagy has recently been challenged [5]. 
Parkin expression is restrictive and inactivation of the protein in mice produces no discernible 
phenotype [25]. Recent work from our lab as well as others suggest that Mulan is involved in a 
mitophagy pathway that is independent of Parkin [26]. Studies have also suggested that Mulan is 
capable of compensating for the loss of PINK1/Parkin and that expression of wild-type Mulan 
can suppress the PD phenotype when PINK1/Parkin are mutated or when Mfn2 is overexpressed. 
Additionally, fly mutants have shown that the removal of Mulan in PINK1/Parkin mutants 
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results in aggravated PD phenotype and double knockouts (PINK1/Mulan or Parkin/Mulan) 
result in further muscle degeneration and potential lethality. Mouse cortical neurons with Parkin 
KO or Mulan KD (knock down) have shown decreased mitochondrial membrane potential.  
Interaction between Mulan and PINK1/Parkin is thought to not be direct, but exist 
through Mfn2: analysis of HeLa cells show stabilization of Mfn2 when Mulan is not present 
(Parkin is not expressed in HeLa cells and does not confound) [5].  
Mulan has also been found to be directly regulated by the mitochondrial Omi/HtrA2. Omi 
is a serine protease that normally resides in the IMS, exhibiting a role in mitochondrial 
homeostasis with protein quality control. Additionally, Omi is released into the cytosol and 
participates in apoptosis during stress. Inactivation of Omi’s protease ability by a single mutation 
(S276C) leads to the mnd2 (motor neuron degeneration 2) phenotype in mutant mice, exhibiting 
neurodegeneration, premature aging, muscle wasting, and parkinsonian features [26].  
We have previously found that Mulan is a substrate of Omi and that mnd2 mutant mice 
show an accumulation of Mulan in their tissues. It is thought that Mulan’s increase results in 
mitochondrial dysfunction that mirrors mitochondrial uncoupling and leads to mitophagy. 
Imbalance in mitochondria numbers may result in energy deficiency for high-energy consuming 
cells, including muscle cells, neurons, and cardiomyocytes, leading to the observed mnd2 
phenotype. Omi interacts with a domain of Mulan that is similar in residue sequence to a known 
substrate of Omi, Inhibitor of Apoptosis Proteins [26]. Omi is thought to be phosphorylated by 
PINK1 before interacting with Mulan (24). 
Further support of Mulan’s role in mitophagy comes from studies where Mulan was 
shown to ubiquitinate ULK1 in the regulation of selenite-induced mitophagy [27]. 
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Figure 4: PINK1 and Parkin mechanism in damaged mitochondrial removal 
 
In healthy mitochondria, the kinase PINK1 is transported into the OMM and IMM by TOM and 
TIM, respectively. Normal degradation then occurs with PARL and MPP. In damaged 
mitochondria, PINK1 becomes trapped inside TOM, and phosphorylates Mfn2, which attracts 
Parkin E3 ubiquitin ligase to the mitochondria for phosphorylation. Parkin then ubiquitinates 
many mitochondrial proteins, including p62, which binds LC3 and initiates autophagosome 
formation.  
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1.4 Mulan E2 Interactors 
   
Mulan is an E3 ubiquitin ligase and as such it will interact with specific E2 conjugating 
enzymes in order to carry out its function. Our lab recently identified four specific E2 
conjugating enzymes as specific interactors of Mulan in a yeast two-hybrid screen of a HeLa 
cDNA library. These enzymes are: Ube2E2, Ube2E3, Ube2G2, and Ube2L3. In addition, a 
modified yeast two-hybrid screen was used where Mulan’s RING domain was fused to each of 
the E2s to isolate potential substrates for the Mulan259-352-E2 complex. GABARAP was isolated 
as a key interactor for the Mulan259-352-Ube2E3 fusion protein; this protein is a member of the 
Atg8 family and participates in mitophagy, a potential link in subsequently explaining Mulan’s 
participation in mitophagy [28] 
 An alternative approach was recently used in our lab where recombinant Mulan-RING 
protein was tested directly against most of the common E2s in an in vitro ubiquitination assay. 
This was done to verify our yeast two-hybrid system results and to overcome a potential problem 
that not all E2s might be present in the HeLa cDNA library. The profiling assay identified 
Ube2D1, Ube2D2, Ube2D3, and Ube2E3 as very likely partner conjugating enzymes for Mulan 
(Figure 9).  
 By studying Mulan’s E2 interactors, we hope to gain further insight into a pathway by 
which Mulan E3 ubiquitin ligase regulates mitophagy and cell death following mitochondrial 
stress, and how the inactivation of this pathway may be responsible for mnd2 phenotype in mice.  
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CHAPTER 2: MATERIALS AND METHODS 
2.1 Overview of the Yeast Two-Hybrid System 
 
The yeast two-hybrid system was used to verify and confirm protein-protein interactions 
between Mulan’s RING domain and its anticipated E2 interactors: Ube2D1, Ube2D2, and 
Ube2D3. Ube2E3 acted as a positive control. In the yeast two-hybrid (Figure 5), the protein of 
interest and its potential interactor are separately cloned into different plasmid vectors, the 
plasmids are transformed into yeast, expression is induced, and the produced proteins may 
interact with each other and with an already present yeast plasmid to produce a color change 
[29].    
The protein of interest, Mulan259-352, is fused to a LexA DNA binding domain (BD) and 
cloned into a pGilda vector. This is known as the bait. The LexA DNA binding domain 
component oversees the locating and binding of the bait to the Upstream Activation Sequence 
(UAS) for the lacZ reporter gene located on the pSH18-34 yeast plasmid. A collection of 
potential protein interactors from a HeLa cDNA library are then fused with an activation domain 
(AD) and cloned into a pJG4-5 vector. These are known as the prey. If the bait interacts with an 
unknown prey, then the binding domain and the activation domain will be in close enough 
proximity to create the full, functional transcription factor at the UAS (the complex: UAS-BD-
Bait-Prey-AD). This leads to the transcription of the lacZ reporter gene for the synthesis of beta-
galactosidase and leucine (Figure 5). The gene for leucine is not located on the pSH18-34 
plasmid, however, its transcription is managed at the same promoter, providing a check that the 
proper plasmid is present and functioning [29].  
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In the presence of X-gal and galactose, the beta-galactosidase cleaves X-gal and a blue 
color is produced. This positive interaction must be further tested to determine if it is a true 
interaction between the proteins. 
 This yeast two-hybrid was abridged since the Ube2D prey were already isolated. A 
complete scan of the library was unnecessary as we were looking specifically for interactions 
implied in the in vitro profiling assay for Mulan. Second, Mulan259-352 was previously cloned into 
pGilda and transformed into EGY48 yeast for past experiments, and this stock was used. 
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The bait consists of Mulan259-352 fused to a LexA-DNA binding domain and it is expressed in yeast. 
The prey is the full length E2 protein fused to the Activation domain (AD). If the prey interacts 
with the bait, it will activate transcription of the reporter gene (usually -galactosidase) and yeast 
will turn blue  
  
Figure 5: Schematic diagram of the yeast two-hybrid system 
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2.2 Construction of pJG4-5-Ube2D Prey 
 
2.2.1 Polymerase Chain Reaction 
Prey Primer Construction: 
Ube2D1: 5’ (EcoR1) – 5’ GGC GAA TTC ATG GCG CTG AAG AGG ATT CAG 3’ 
     3’ (Xho1) – 5’ CCG CTC GAG TTA CAT TGC ATA TTT CTG AGT CCA 3’ 
 
Ube2D2: 5’ (EcoR1) – 5’ GGC GAA TTC ATG GCT CTG AAG AGA ATC CAC 3’ 
     3’ (Xho1) – 5’ CCG CTC GAG TTA CAT CGC ATA CTT CTG AGT 3’ 
 
Ube2D3: 5’ (EcoR1) – 5’ GGC GAA TTC ATG GCG CTG AAA CGG ATT AAT AAG G 3’ 
     3’ (Xho1) – 5’ CCG CTC GAG TCA CAT GGC ATA CCT CTG AGT CCA 3’ 
 
 DNA for Ube2D1, Ube2D2, and Ube2D3 was amplified with the preceding primers at 
EcoR1 and Xho1 restriction enzyme sites. The PCR mix included: 1 µl of DNA Template, 100 
µM of Forward Primer (eurofins), 100 µM of Reverse Primer (eurofins), 1 µl of dNTPs 
(Clontech), 5 µl of (10x) PCR Running Buffer (NEB), 40.8 µl of sterile water, and 0.2 µl of 
TAQ Polymerase (Roche Diagnostics Corp). The thermocycler abided by the following: 2 
minutes of template denaturing at 95 ⁰ C, 29 cycles, and a final elongation period of 7 minutes at 
72 ⁰ C. Each cycle consisted of denaturing at 95 ⁰ C for 30 seconds, primer annealing at 56 ⁰ C 
for 30 seconds, and TAQ Elongation at 72 ⁰ C for 35 seconds. Samples were kept on ice. 
Template DNA for Ube2D2 was taken from a HeLa library.  
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2.2.2 Agarose Gel Electrophoresis 
 Gels were prepared by adding 1.5 g of agarose powder (Promega) to 100 ml of (1x) TAE 
DNA Running Buffer. Microwaving for 2 minutes with intermittent solution swirling permitted 
the agarose to dissolve. 5 µl of ethidium bromide, the UV-associated viewing agent, was added 
while the solution was warm. Solution was then poured into a gel casket with two combs. Gel 
was left to solidify during the cooling process. After cooling, the combs were removed, and the 
gel was cut to give the appropriate quantity of wells. TAE buffer was poured over the gel, filling 
the casket, until the gel was fully immersed. Sample preparation included combining 2 µl of PCR 
DNA with 5 µl of DNA dye. The GeneRuler 1 kb plus DNA ladder (ThermoFisher) of multiple 
known DNA sizes was pipetted into the first well, and then each of the samples were added. 
Viewed with a gel doc, ethidium bromide fluorescence indicated the location and comparative 
size of DNA samples. 
 
2.2.3 Precipitation 
 PCR product was precipitated to remove residual salts from the PCR buffer solution and 
to further purify the amplified DNA. Sample volume was brought up to 100 µl with water. 10 µl 
of sodium acetate (10% of sample volume) and 200 µl of (100%) ethanol (2x the sample 
volume) were added. Tubes were inverted several times and stored at -20 ⁰ C for 30 minutes. 
Next, tubes were spun at 13,200 rpm for 20 minutes within a 4 ⁰ C fridge. Supernatant was 
removed, pellet was dried in a speed vacuum for 15 minutes, and re-suspended in 50 µl of water. 
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2.2.4 Restriction Enzyme Digestion  
 5 µl of precipitated DNA (Ube2D1, Ube2D2, and Ube2D3 inserts, and stock pJG4-5 
vector), 5 µl of (10x) Restriction Enzyme Buffer (NEB), 0.5 µl of (100x) BSA (NEB), 41.5 µl of 
dH2O, and 1 µl of restriction enzyme were combined and incubated in a 37 ⁰ C water bath. After 
an hour, 0.5 µl more enzyme was added, and incubation continued for another hour. This was 
performed first using Xho1 restriction enzyme, and then separately conducted using EcoR1 
restriction enzyme, each with their appropriate buffer. Next, the insert DNA was precipitated, 
and the 4-5 vector DNA was ran on a 1.5% agarose gel, extracted and purified according to the 
methods in the Gel DNA Recovery Kit (Zymoclean). 50 µl of dH2O was added to the samples to 
bring the volume up to 100 µl. Samples were precipitated.  
 
2.2.5 Ligation 
 2 µL of digested DNA was run on a 1.5% agarose gel and the quantity of DNA within 1 
µl of insert and 1 µl of 4-5 vector was estimated. DNA used for ligation should be 3:1 for the 
vector to insert ratio. Each sample received 4 µl of vector, varied insert DNA (7 µl Ube2D1, 7 µl 
Ube2D2, 5 µl Ube2D3, 0 µl (Negative control), 3 µl of (5x) buffer, 1 µl of ligase, and enough 
dH2O to bring each sample up to 15 µl. Samples were incubated at room temperature for 20 
minutes. 35 µl of dH2O was added to bring the samples up to 50 µl. Desalting occurred with the 
addition of 500 µl of (10x) butanol. Tubes were inverted several times and spun at 13,200 rpm 
for 15 minutes. Butanol was removed by pipette and tubes were dried for 15 minutes in a speed 
vacuum. Pellet was resuspended in 10 µl of dH20. 
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2.2.6 Bacterial Transformation 
 Electrocompetent bacteria cells (Dh5α) were retrieved from a -80 ⁰ C freezer and thawed 
slowly on ice. Electroporation cuvettes were also chilled. 3 µL of ligated DNA was added to the 
tube of thawed bacteria cells (50 µL) and the entire solution was transferred to its respective 
cuvette. The Gene Pulser (Bio Rad) was set to 2.5 kV at 400 Ω. After electroporation, 800 µL of 
LB was quickly added to each cuvette, mixed, and transferred to a fresh tube. Samples were 
incubated by rotator for 1 hour at 37 ⁰ C. 250 µL of each sample was then plated on LB + AMP 
plates, with plastic beads (Fisher) to spread, and left to incubate over-night (O/N). Grown 
colonies were selected the following day and added to 1.5 ml of LB + AMP broth. Tubes were 
also incubated O/N.  
 
2.2.7 Isolation of Plasmid from Bacteria: DNA-Boiling Miniprep 
 Cells and media were transferred into 1.5 mL Eppendorf tubes and spun at 13,200 rpm 
for 2 minutes at room temperature (RT). The supernatant was removed by aspiration and the 
pellet was resuspended in 300 µL of STET-lysozyme solution (8% sucrose, 5% (100X) Triton, 
50 mM Tris-HCl pH 8, 50 nM of EDTA, 10 mg/mL of lysozyme). Samples were then boiled for 
1 minute and spun at 13,200 rmp for 10 minutes. Mucus pellets were removed with a toothpick. 
200 µL of (70%) isopropanol was added, and tubes were mixed by inverting. Samples were spun 
again at 13,200 rpm for 10 minutes. Isopropanol was removed by pouring out the supernatant in 
one motion. 200µL of (70%) ethanol was added with no mixing. Samples were spun at 13,200 
rpm for 5 minutes. Ethanol was also removed by pouring out the supernatant in one motion and 
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the tubes were dried in a speed vacuum for 15 minutes. Pellets were resuspended in 100 µL of 
Tris-EDTA (TE) and vortexed using a Fisher Vortex Genie 2 for 10 minutes. 
 
2.2.8 Isolation of Plasmid from Bacteria: DNA QIAprep Spin Miniprep 
 The methods suggested within the QIAprep Spin Miniprep Kit (QIAgen) were used. 
Bacteria grown O/N was spun at 11,2000 rpm for 2 minutes. Supernatant was aspirated out and 
the pellet was resuspended in 200 µL of Buffer P1, which contains lysozyme and RNAse. Then, 
200 µL of Buffer P2 was added, which contains SDS, tubes were inverted to mix and left at RT 
for 5 minutes. 250 µL of Buffer N3 was added, the tubes were inverted to mix, and spun at 
11,2000 rpm for 10 minutes. Supernatant was loaded into a QIAprep spin column and 
centrifuged for 1 minute. The flow through was discarded, the column was washed with 600 µL 
of Buffer PB, and tubes were centrifuged for 3 minutes. A subsequent wash occurred. The 
column was spun for 1 more minute to dry. Finally, the QIAprep spin column was placed in a 
fresh 1.5mL Eppendorf tube and the column was eluted with 50µL of Buffer EB (10 mM Tris-Cl 
pH 8.5) before a final centrifugation for 1 minute.  
 
2.2.9 Restriction Enzyme Double Digestion 
To test which DNA samples contained a successfully transformed plasmid-insert 
combination, a double digestion with EcoR1 and Xho1 was performed. A master mix was 
prepared and equally distributed to a fresh 50 µL Eppendorf tube per sample. Each sample 
contained: 11.4 µL of dH2O, 2 µL of (10X) Restriction Enzyme Buffer (NEB), 0.2 µL (100X) 
BSA (NEB), 0.2 µL of EcoR1, and 0.2 µL of Xho1. 6 µL of DNA brought each sample up to 20 
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µL. All samples were incubated at 37 ⁰ C for 2 hours. 2 µL of each digested sample was then run 
on an agarose gel with RNAse loading dye and tested by visualization to determine insert 
presence. Clean DNA samples from the mini prep that contained the desired insert were stored at 
20 ⁰ C. 
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2.3 The Yeast Two-Hybrid 
 
2.3.1 Yeast Drop-Out Medium 
 Yeast drop-out powder (Sigma) consists of all 20 amino acids except the amino acids 
desired for drop-out mediums. The yeast two-hybrid plasmids associated with this study have 
selectable markers that permit them the ability to self-produce certain amino acids; a colony’s 
presence in drop-out medium specific to an amino acid the plasmid can produce, therefore, 
indicates the plasmid’s presence within the colony. To distinguish yeast pSH18-34 plasmid, 
uracil (U-) is left out from the medium (Figure 6). To distinguish the presence of pGilda after 
transformation, histidine (H-) is left out (Figure 7), and to distinguish the presence of pJG4-5 
after transformation, tryptophan (W-) is left out (Figure 8). Expression for all of the vectors are 
under the GAL1 promoter and can be induced in the presence of galactose and repressed in the 
presence of glucose. 
 Yeast drop-out medium consisted of the following: 1 g dropout powder (Sigma), 3.35 g 
Yeast Nitrogen Base (Sigma), 10 g glucose or 10 g galactose and 5 g raffinose dissolved in dH2O 
to a volume of 500 ml, and 10 g agar (Apex) if the medium was for plates. Solution was 
autoclaved for 40 minutes and cooled before the addition of 50 ml (10X) BU salt and 1 ml X-Gal 
if the medium was for blue-white screening. Media with agar was poured into plates, left to 
solidify, and stored at 4 ⁰ C, while bottled non-agar media was left at room temperature.  
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Figure 6: EGY48 yeast pSH18-34 vector 
 
A LacZ reporter plasmid present in the EGY48 yeast strain and replicated with the 2 µm origin. 
Expression of LacZ is controlled by 8 LexA operators with the GAL1 promoter. Additionally, 
URA3 serves as a selectable marker and the ampR enables ampicillin resistance.  
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Figure 7: pGilda vector used for Mulan259-352 bait cloning 
 
A cloning vector that fuses the bait protein of interest with LexA, which acts as the DNA binding 
domain. The ARS/CEN ori is used to replicate in yeast using the GAL1 promoter. HIS3 serves as 
the selectable marker and ampR is present for ampicillin resistance. Cloning utilizes the EcoR1 
and Xho1 restriction sites.  
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Figure 8: pJG4-5 vector used for Ube2D prey cloning 
 
A cloning vector that fuses the prey proteins with B42, which acts as the DNA Activating 
Domain. The 2 µm ori is used to replicate in yeast using the GAL1 promoter. TRP1 serves as the 
selectable marker and ampR is present for ampicillin resistance. Cloning utilizes the EcoR1 and 
Xho1 restriction sites. Additionally, this vector includes a nuclear localization sequence (NLS) 
and a hemagglutinin (HA) epitope tag. 
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2.3.2 Yeast Transformation  
 50 
ml U- H- glucose medium was inoculated with a single EGY48 yeast colony and grown shaking 
O/N at 30 ⁰ C; this colony was stock from previously transformed yeast with LexA-Mulan259-352 
and, therefore, possessed not only the normal yeast plasmid pSH18-34, but also pGilda. Cells 
were harvested at 38,000 rpm (Allegra 6R Centrifuge) for 5 minutes. The supernatant was 
poured out and the cells were washed with 10 ml of TE pH 7.5 (10 mM Tris pH 5, 1 mM EDTA 
pH 8). Cells were spun for 5 minutes and the TE was poured out. Cells were resuspended in 5 ml 
LA (0.1 M LiAC in TE) and incubated shaking at 30 ⁰ C for 2 hours. Cells were spun at 3,000 
rpm for 5 minutes and the LA was poured out. Cells were resuspended in 5 ml of LA. Salmon 
sperm DNA (SS DNA) was boiled for 5 minutes. 300 µL aliquots of yeast + Mulan259-352 cells, 2 
µL of denatured SS DNA , and 5 µl of clean (miniprep) prey DNA were combined for 
transformation. 700 µL PEG (50% Peg 4000 in LA) (Sigma) was added to the solution, and 
resuspended to mix. Incubation occurred in a 30 ⁰ C water bath for 30 minutes. Cells were heat 
shocked for 15 minutes at 42 ⁰ C in a second water bath and collected by centrifugation at 
13,200 rpm for 3 minutes. Supernatant was aspirated, and the pellet was resuspended in 300 µL 
of TE pH 7.5. 100 µL of transformed yeast was plated on U- H- W- glucose plates and grown for 
2 days. Grown colonies were selected the following day and added to 1.5 mL of U-H-W- glucose 
media. Tubes were also incubated O/N. 
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2.3.3 Yeast Induction 
 Cells and media were transferred into 1.5 ml Eppendorf tubes and centrifuged at 32,000 
rpm for 3 minutes. Supernatant was poured out and 1 ml of  U-H-W- galactose/raffinose media 
was added to wash. After centrifugation for 3 minutes, the supernatant was aspirated out and 500 
µL of fresh U-H-W- galactose/raffinose was added. Yeast was resuspended with vortexing. An 
additional 1 ml of U-H-W- galactose/raffinose media was added to the Eppendorf tubes and 1 ml 
of U-H-W- glucose media was added to the original incubation tubes. New and old tubes were 
incubated for 4 hours at 30 ⁰ C. Cells and media were then transferred to fresh tubes, spun, and 
the supernatant was removed. 100 µL of ESB (2% SDS, 80mM Tris pH 6.8, 10% glycerol, 1.5% 
DTT, and 0.1 mg/ml bromophenol blue) was added to the yeast samples and to Ube2D1 and 
Ube2E3 non-induced samples for control. Resuspension revealed blue coloring. Samples were 
boiled for 5 minutes, vortexed thoroughly, boiled for an additional minute, and spun down to 
collect. Samples were stored at -20 ⁰ C. 
 
2.3.4 Yeast SDS PAGE and Western Blot 
 Induced and non-induced sample supernatant was analyzed using SDS PAGE with the 
12% resolving and 5% stacking gels. Samples were prepared with the addition of 5 µL (4X) 
sample buffer (10% β-mercaptoethanol, 6% SDS, 20% glycerol, 1/40 stacking buffer, and 0.2 
mg/ml bromophenol blue) to 20 µl of supernatant and 1 minute of boiling. A western transfer 
was performed using a PVDF membrane. The membrane was activated with 10 ml methanol, 10 
ml (5X) TBS buffer and 30 ml dH2O before transfer. α-HA (Sigma) (binds to the prey-fusion 
protein) mouse monoclonal primary antibody was diluted 1: 5,000 in 2% milk-TBST (250 mM 
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Tris pH 8, 1.25 M NaCl, and 0.1% Tween20) and α-LexA-HRP (SC) (binds to the bait-fusion 
protein) mouse monoclonal primary antibody was diluted 1: 500. After blocking with milk and 
washing with TBST, the membrane was incubated O/N at 4 ⁰ C shaking with the appropriate 
primary antibody. The membrane was washed, rabbit α-mouse, HRP conjugated secondary 
antibody (Jackson ImmunoResearch) diluted 1: 10,000 was used for 1-hour incubation, and the 
membrane was washed again. Protein visualization occurred using the chemiluminescence ECL 
kit (PIERCE). Blue sensitive autoradiography film (MIDSCI) was used for development in a 
SRX-101A (Konica). 
12% resolving gels consisted of the following: 8 ml 40% acrylamide mix (BioRad), 10 
ml dH2O, 6.3 ml 1.5 M Tris pH 8.8, 250µL 10% SDS, 250µL 10% APS, and 10µL TEMED 
(Fisher). 5% stacking gels consisted of the following: 1.25 ml 40% acrylamide mix (BioRad), 7.3 
ml of dH2O, 1.25 ml 1.0 M Tris pH 6.8, 100µL 10% SDS, 100µL 10% APS, and 10 µl TEMED 
(Fisher). 
 
2.3.5 Yeast Streaking and Spotting 
 Colonies from the yeast transformation were selected and streaked onto a U-H-W- glucose 
plate. Colonies that grew on this master plate were used to streak a U-H-W- galactose / raffinose 
plate. Results were photographed 2 days later. 
The remaining protein-induced yeast was vortexed and transferred to a fresh 2 ml tube. 5 
µl was used to spot a U-H-W- galactose / raffinose plate. Results were photographed the next day. 
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2.4 Mouse Tissue Analysis 
 
2.4.1 Mouse Tissue Preparation 
 Tissue from the brain, heart, liver, and kidneys were extracted from wild-type mice. 
Homogenization was performed with an ULTRA TURRAX (IKA) for all samples besides the 
brain, which was done by hand. A Bradford assay was performed to determine protein 
concentration and quantity of each sample needed for the equalized loading of 20 µg. Sample 
buffer was added, the samples were boiled for 1 minute, and they were briefly spun down to 
collect. Samples were stored at -20 ⁰ C [30]. 
 
2.4.2 Mouse Tissue SDS PAGE and Western Blot 
 Techniques were performed as previously described. Primary monoclonal antibodies 
included: rabbit α-Ube2D1 (Abcam), α-Ube2D2 (Abcam), α-Ube2D3 (Abcam), and α-Ube2E3 
(Novus Biologicals) diluted 1: 5,000. Secondary antibodies included goat α-rabbit, HRP 
conjugated (Jackson ImmunoResearch) diluted 1: 10,000. GAPDH was used as a loading control 
in each gel. 
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CHAPTER 3: RESULTS 
3.1 Transformation and Screening of Mulan259-352 Interactors 
 
Our lab’s previous yeast two-hybrid screen isolated both Ube2E2 and Ube2E3 as bona 
fide interactors of Mulan259-352 [28]. The in vitro profiling assay identified these two, as well as 
three additional E2s: Ube2D1, Ube2D2, and Ube2D3 (Figure 9). 
 To verify the validity of interaction for these proteins, Ube2D1, Ube2D2, and Ube2D3 
were separately cloned in-frame into pJG4-5 vectors as described in Chapter 2. This yeast two-
hybrid was abridged since the Ube2D prey were already identified, making the HeLa library scan 
unnecessary. Yeast cells pre-transformed with Mulan259-352 were transformed with the 
synthesized prey and streaked onto U- H- W- glucose + X-gal plates and U- H- W- galactose / 
reffinose + X-gal plates following induction. All three of the Ube2D prey showed an intense blue 
color on the galactose / raffinose plates (Figure 10). 
Ube2D1, Ube2D2, and Ube2D3 have approximate molecular weights of 11 kDa. The HA 
tag and other proteins associated with the pJG4-5 vector have an estimated molecular weight of 
about 14 kDa. Therefore, HA-Ube2D fusion proteins should have an approximate molecular 
weight of 25 kDa (Figure 11). 
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An in vitro ubiquitination assay that uses recombinant His-Mulan259-352 with each of the indicated 
E2 enzymes. Ube2D3, Ube2E3, Ube2D2, Ube2D1 conjugating enzymes were able to work 
efficiently with Mulan259-352 in this assay. E2 proteins previously identified in our lab through the 
yeast two-hybrid are boxed in red and new proteins are boxed in blue. 
  
Figure 9: Results of the E2 selection and profiling assay for Mulan 
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Figure 10:Interaction of the various E2 enzymes with Mulan259-352 in yeast 
 
Full length Ube2D1, Ube2D2, and Ube2D3 were cloned in-frame in the pJG4-5 vector and 
transformed in yeast expressing LexA-Mulan259-352 bait. Ube2E3 was previously cloned and 
characterized in our lab. Interaction between the bait and the different prey was tested on X-gal 
plates. Blue color indicates a positive protein-protein interaction.  
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Figure 11: Expression and stability of HA-E2 prey in yeast cells 
 
Western blot analysis showing induced (i) and non-induced (ni) yeast expression for Ube2D 
family members and Ube2E3. Primary antibody used was α-HA (Sigma). Lane 1: Induced 4-5 
vector. Lane 2: Non-induced Ube2D1. Lane 3: Induced Ube2D1. Lane 4: Induced Ube2D2. Lane 
5: Induced Ube2D3 Clone A. Lane 6: Induced Ube2D3 Clone B. Lane 7: Non-induced Ube2E3. 
Lane 8: Induced Ube2E3. 
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3.2 Tissue Specific Expression of Mulan259-352 Interactors 
 
 To investigate the expression of the various E2s in mouse tissues, brain, heart, kidney, 
and liver tissue homogenates were prepared as described in Chapter 2 and analyzed by SDS-
PAGE and Western blotting. Antibodies used were monoclonal rabbit α-Ube2D1 (Abcam), α-
Ube2D2 (Abcam), α-Ube2D3 (Abcam), and α-Ube2E3 (Novus Biologicals).  
Figure 12 shows that the expression and protein levels are very similar between all four 
E2s in the mouse tissues tested. Highest expression is seen in the brain and lowest in the heart. 
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Figure 12: Tissue specific expression and protein levels of various E2 partners of Mulan 
 
Western blot analysis showing the expression of Ube2D1, Ube2D2, Ube2D3, and Ube2E3, 
proteins in mouse tissues. GAPDH was used as a loading control. 
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3.3 Characterization of Ube2D Interactors 
 
 There are four members of the Ube2D family, including Ube2D1, Ube2D2, Ube2D3, and 
Ube2D4. Protein sequences among the three studied family members are high in homology. 
NCBI BLAST indicates that Ube2D1 shares 89% identity with Ube2D2 and 88% identity with 
Ube2D3. Ube2D2 and Ube2D3 share 97% identity (Figure 13). Since these proteins are all E2 
conjugating enzymes, it follows that high homology should mark similar functioning in certain 
areas. 
 Not much is known about the Ube2D family and their definitive roles in the cell, 
however, the research has encompassed a variety of molecular processes. One of the first studies 
described cadmium (Cd) exposure, a cause of renal dysfunction, decreasing Ube2D family 
expression in rat renal tubular epithelial (NRK-52E) and human cells. It was hypothesized that 
the inhibition of the Ube2D proteins enabled p53 accumulation and p53-dependent apoptosis 
under Cd exposure [31]. Results varied for different cell types and pointed to an association of 
Cd to renal toxicity, but not hepatic toxicity in mice. Human brain astrocytes (HBASTs) 
uniquely showed Cd increasing Ube2D3 expression [32]. Inorganic arsenic also increased p53 
expression, and it decreased expression in Ube2D1 and Ube2D2, but not in Ube2D3, within 
NRK-52E cells. Inorganic mercury did not affect p53 or Ube2D protein levels. It was suggested 
that arsenic, but not mercury, increased p53-dependent apoptosis through the suppression of 
Ube2D proteins like Cd [33]. 
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Alignment for Ube2D1, Ube2D2, and Ube2D3 proteins shows high sequence homology. 
Asterisks indicate sites of varied amino acid residues. Coloring corresponds to amino acid 
properties.  
  
Figure 13: Protein sequence alignment for Ube2D family members 
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3.4 Characterization of Ube2D1 
 
 Ube2D1 has been shown to interact with the RING finger of two E3 ubiquitin ligases 
besides Mulan. The herpes simplex virus, for example, requires the E3 ubiquitin ligase ICP0 for 
proper initiation of the lytic cycle of infection and degradation of proteins involved in DNA 
repair, centromere assembly, and antiviral proteins. The study pointed to Ube2D1 being a key 
component to the system by which ICP0 initiates activation from viral quiescence [34]. Second, 
Ube2D1 has been shown to interact with the E3 ubiquitin ligase March-I. Normal function for 
March-I involves lowering the expression for MHC-II and CD86 proteins in antigen presenting 
cells, proteins that mediate CD4 T cell activation. Ube2D1 is thought to aid in the ubiquitination 
of March-I itself with an unknown E2, leading to March-I expression decrease and the 
upregulation of MHC-II [35]. 
 Lastly, Ube2D1 has been questioned for its potential influence in neurodevelopmental 
processes that may be linked to schizophrenia; Ube2D1’s selection was based on its association 
with the p53 pathway and its location at the chromosome region 10q21.1, which is adjacent to 
the ANK3 gene, a likely schizophrenia relation found in previous single nucleotide 
polymorphism (SNP) studies. SNPs in Ube2D1 for a case-control study did not correlate with 
schizophrenia for this population, however, there was an observed reduction in the risk of cancer 
for the patients over the decade study, surmised to be related to potential polymorphisms in p53 
[36]. Ube2D1 continued to be involved in study due to its relation to long-term 
neurodevelopmental effects and altered brain function upon dysfunction. In follow up research, 
Ube2D1 showed no difference in basal concentrations for post-mortem schizophrenia patients 
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within the dorsolateral prefrontal cortex; however, Ube2D1 was significantly increased in mice 
under phencyclidine (PCP) treatment, a model for schizophrenia, at the juvenile time point [37]. 
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3.5 Characterization of Ube2D2 
 
 The least amount is known about Ube2D2 among the three Ube2D family members 
analyzed. Perhaps the most important relationship studied for this protein is Ube2D2’s supported 
regulation of Parkin in Parkin-dependent mitophagy. 
  The knockdown of Ube2D2 is correlated with a reduction in the clearing of depolarized 
mitochondria with autophagic mechanisms, though the process of PINK1 membrane-embedding 
and Parkin translocation remains constant; this may point to redundancy in E2 action. 
Knockdown of Ube2D2 with additional E2 knockdowns (Ube2N and Ube2L3) goes further to 
decrease Parkin polyubiquitination of the mitochondria and decrease p62 recruitment [38].  
Parkin is now thought to exhibit mechanistic features similar to the HECT ubiquitin 
ligase family: the RING Ube2D-binding domain is covered and autoinhibited. PINK1 
phosphorylation permits the domain release, Ube2D2 can form a thioester bond to Parkin, and 
ubiquitination follows. Knockdown of specific E2 partners, therefore, directly relates to 
decreased Parkin ubiquitination and subsequent mitophagy [38]. Specifically, Ube2D2 with 
Parkin can monoubiquitinate Mfn1 [39].     
An identical relationship with Parkin was also linked to Ube2D3 [38]. 
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3.6 Characterization of Ube2D3 
 
 Ube2D3 has been studied with high consideration for tumorigenesis and cancer 
progression; it was found to interact with human telomerase reverse transcriptase (hTERT). 
hTERT expression usually correlates to telomerase activity and activation, leading to radio 
resistance for cancer cell lines, which was countered with Ube2D3 presence. Downregulation of 
Ube2D3 resulted in hTERT and cyclin D1 accumulation, cell proliferation, and quicker 
transitions from G1 to S phase in human breast cancer cells (MCF-7) [40]. Ube2D3 was also 
found to be significantly lower in esophageal cancer lines. The negative correlation linkage 
between hTERT and Ube2D3 demonstrated a strong predicting factor for the progression of 
human esophageal cancer [41]. Additionally, further study with esophageal squamous carcinoma 
cells (EC109) indicated that Ube2D3 overexpression prolonged G1 phase, decreased telomere 
length, and enhanced radio sensitivity again through the degradation of hTERT, reiterating the 
proposed link found in MCF-7 lines [42]. These results were consistent in Eca-109 cells and it 
was further showed that downregulating Ube2D3 led to faster DNA repair after IR exposure 
[43]. This data suggests that Ube2D3 manipulation might provide benefits for advancing radio 
therapy due to its supported link in cell-cycle control, DNA damage repair, and tumorigenesis 
[41]. However, care should be taken after considering the Ube2D family’s abundant involvement 
in alternative pathways. 
 Second, Ube2D3 has been shown to aid in the ubiquitination of RIG-1, which induces the 
aggregation of MAVS on mitochondria. This leads to downstream activation of transcription 
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factors and initiation of the innate immune response for viral protection through type I interferon 
production [44].  
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CHAPTER 4: DISCUSSION 
 
 The natural mitochondrial cycle involves a continual flow between fission and fusion. 
Fission can result in unequal mitochondria sharing and the creation of a depolarized membrane 
for one of the daughters [11-13]. This shift from homeostasis creates an increase in 
ubiquitination and may lead to mitophagy, a form of autophagy that destroys damaged 
mitochondria [20-23]. If the cell cannot manage the excessive damage, the cell may engage in 
apoptosis. Mitophagy and apoptosis can lead to disease since an imbalance in mitochondria may 
starve cells of energy and lead to neurodegeneration, muscle atrophy and wasting, and 
parkinsonian phenotype [26]. 
Mulan is an E3 ubiquitin ligase that has been implicated in all of these steps towards 
disease through interactions with its RING finger domain [1] (Figure 14). Though much research 
has been done concerning Mulan’s RING domain, there has been less focus on the full 
classification of Mulan’s E2 interactors, their role in a Mulan-derived pathway for mitophagy, 
and the potential link to mnd2 mutant mice phenotype. Previously in our lab, a yeast two hybrid 
system was used that identified Mulan interactors. In that study, the RING domain of Mulan 
(amino acids 259-352) served as bait in a yeast two-hybrid screening and potential interactors 
were cloned into pJG4-5. Strong and comparable protein-protein interactions were confirmed to 
exist between Mulan and the full-length E2 conjugating enzymes, Ube2E2 and Ube2E3. Since 
the yeast two-hybrid system has limitations, an in vitro ubiquitination assay with a recombinant 
Mulan-RING domain was used to monitor potential activity with these E2s and any additional 
E2 interactors that were not shown in the yeast two-hybrid. This screen identified the same 
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interactors, Ube2E2 and Ube2E3, as well as three additional E2s: Ube2D1, Ube2D2, and 
Ube2D3. These family members showed considerable promise as strong interactors and potential 
partners (Figure 9). All E2’s were cloned into the pJG4-5 vector as full-length proteins and their 
interaction with Mulan’s RING domain was tested side by side. They all showed strong positive 
interaction with the Mulan bait (Figure 10). 
Therefore, we have shown that Ube2D1, Ube2D2, and Ube2D3 are able to interact with 
Mulan and work with it in an in vitro ubiquitination assay. This data strongly supports the notion 
that these interactions are real, functional and can potentially exist within mammalian cells. 
 Ube2D1, Ube2D2, and Ube2D3 have been previously studied and are known to be 
involved in contending p53-directed apoptosis, neurodegeneration in juvenile mice, possessing 
anti-cancer properties, aiding in innate immunity, aiding in the viral lytic cycle, and regulating 
the Parkin-dependent mitophagy [31-44]. Though these proteins possess high homology and 
some similar roles, their independent functions have a wide variance. This indicates the potential 
for different interactions with Mulan.   
Since Mulan as an E3 ubiquitin ligase can only interact with one E2 at a time, we 
investigated if the tissue distribution or protein level of the various E2s can determine the 
identity of the Mulan/E2 combination at any time. Ube2D1, Ube2D2, Ube2D3, and Ube2E3 
proteins showed no major differences among each other in their expression levels within the 
tissue types. They also displayed great overlap between tissues, indicative of ubiquitous activity.  
One result of significance was the high levels of E2 protein expression in the brain, as 
opposed to the expression in the heart, kidney, and liver (Figure 12). This directly points to 
Mulan having vital functioning with the brain. Dysregulation of Mulan, therefore, might be 
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responsible for neurodegeneration and a related loss of function within the brain – neurons are 
highly energy demanding, therefore, an increase in mitophagy involving Mulan might be 
responsible for phenotype. Since Mulan expression is elevated in mnd2 mutant mice, this data 
might also indicate that the dysregulation of Mulan is responsible for the neurodegeneration 
apparent in mnd2 mice. A second result showed Ube2D expression was lower in the heart 
compared to the liver and kidney samples (Figure 12). This is interesting since Mulan expression 
is typically raised in the heart [1,26].  
This data does not preclude the option that Mulan initiates its own mitophagy through 
collected interactions with other, non-Ube2D interactors. The specific relationship that exists 
between Mulan and Parkin is also still unknown and should be studied further; Mulan is thought 
to be able to prevent PD phenotype in the absence of PINK1/Parkin, yet its accumulation leads to 
PD phenotype in the presence of non-mutated PINK1/Parkin in mice [5,26]. This still points to a 
Mulan-dependent mechanism for mitophagy.             
The next phase of the project has already been initiated. Further in vitro assays were 
performed with Mulan259-352 – E2 protein combinations looking to isolate potential substrates that 
interact with each individual ubiquitination complex. Combinations studied include: Mulan + 
Ube2D1, Mulan + Ube2D3, and Mulan + Ube2E3. Several potential substrates were identified 
for each combination and are being further analyzed. 
Future work should focus on quantifying data for E2 expression in varied tissue samples 
with qPCR since western blot visualization alone is qualitative. Also, assays should be 
performed that involve stressing the cells, isolating the mitochondria and cytoplasm, and 
observing if there were changes in E2 expression present between these locations. This would be 
47 
 
particularly important since the Ube2D proteins are localized within the cytoplasm and must 
migrate to interact with mitochondria-bound Mulan. Lastly, it would also be interesting to 
conduct temporal studies in accordance with mice development. This could reveal E2 
characterization specific to time for growth patterns or Mulan-related disease progression. 
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Mulan E3 Ubiquitin Ligase is known to be involved in mitochondrial dynamics, mitophagy, and 
apoptosis. Mulan interacts with Mfn2 and Drp1 to affect fission and fusion; it also activates NF-
κB, p53, and JNK pathways. Mulan itself is regulated by Omi protease during mitochondrial 
stress. Mulan also drives a Parkin-independent pathway to mitophagy.  During mitophagy, 
Mulan interacts with GABARAP and can compensate for the absence of PINK1 and Parkin. As 
an E3 ligase, its activity and substrate specificity are dictated by specific E2 partners. 
  
Figure 14: A schematic diagram of the various functions of Mulan and the proteins involved 
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